International Conference on Cancer Care and Cure - Series II

May 06

Add to My Calendar Time: 08:30 AM - 06:30 PM

May 06, 2019 09:00 AM May 07, 2019 06:30 PM Kuala Lumpur, Malaysia International Conference on Cancer Care and Cure - Series II Kuala Lumpur, Malaysia Clyto Access true MM/DD/YYYY

About Cancer Care & Cure 2019

Considering the growth and developments in Cancer research, Clyto Conferences is hosting and organizing International Conference on Cancer Care and Cure -Series 2 during 06 - 07 May 2019 in Kuala Lumpur, Malaysia. Cancer care and cure 2018 conference mainly focuses on Cancer Epidemiology studies, Genetic makeup - Understanding genetic and lifestyle cause of diseases, Informatics and Computational biology of Cancer study, Imaging and technological advancements in detecting cancer. Clyto Conferences successfully hosted the International conference on cancer care and cure during December 01-02, 2016, at Movenpick Hotel Ibn Battuta Gate, Dubai. The conference focused on the theme “Cancer: Emergence and advancements”. The conference was successful in gathering eminent speakers from various reputed organizations and their paramount talks enlightened the gathering. The pragmatic meeting organized by Clyto Conferences team received a generous response from the Editorial Board Members of Clyto online open access Journals as well as expertise from academia, talented researchers and young student community. Researchers and students who attended from different parts of the world made the conference one of the most successful events in 2016 from Clyto Conferences. The conference was marked by the presence of renowned Speakers, Young Researchers, Students and Business Delegates driving the two-day event into the path of success with thought-provoking keynote and plenary presentations. Cancer Care- 2016 offered comprehensive range of sessions including Cancer Immunotherapy, Types of Cancer, Leukemia, Cancer Biology, Radiation Oncology, Anti-cancer Drugs, Cancer Therapy.


Adjuvant therapy, Barium Enema, Benign cancer, Biopsy, Bone marrow transplant, Breast MRI, Cell Signalling, Computed Tomography scan, Colposcopy, Carcinoma, Clinical trials, Chemoprevention, Chemotherapy, Digital rectal exam, Drug development, Fibroid, Gene Therapy, Hormone therapy, Imaging tests, Carcinoma In situ, Invasive cancer, Integrative medicine, Immunotherapy, Leukemia, Localized cancer, Lymphatic system, MUGA scan, Mamography, Malignant cancer, Metastasis, Mastectomy, Neoadjuvant therapy, Oncology, PET-CT Scan, Pap test, Polyp, PSA test, Pre- malignant, Primary cancer, Palliative care, Placebo, Radiation therapy, Sarcoma, Screening, Secondary cancer, Tumor marker tests, Tumor, Targeted treatment, Tumor genetics.

Abstract submission deadline (1st round)
15 January 2019

Notification of acceptance or rejection of abstract
03-10 working days from the date of submission

Final presentation should be submitted

15 days before the conference date

Early bird registration

30 January 2019


The cancer diagnostics market in Asia is expected to grow at the highest rate from 2015 to 2020. Recent progress in biological therapies has widened the scale of therapeutic targets for treatment of cancer with the identification of tumor cell specific genes. Global Oncology / Cancer diagnostics market is expected to garner $13.1 billion by 2020, from an estimate of $7.1 billion in 2015, registering a CAGR of 12.9% during the forecast period 2014 to 2020. The market is dominated by North America, followed by Europe, Asia, and Rest of the World (RoW). Immunotherapy, Artificial intelligence, Molecular cancer diagnostics, etc are emerging as potential therapies to find the permanent cure for various cancer types. Global cancer drugs market was valued at approximately USD 112.90 billion in 2015 and is expected to generate revenue of around USD 161.30 billion by end of 2021, growing at a CAGR of around 7.4% between 2016 and 2021.


"Latest Development and Novel Treatment for Cancer" will explore the fields of  Cancer Immunology & Vaccines, Cancer Screening & Diagnosis, Innovations in prevention and screening, Biomarkers, Leukemia, health professional cancers, Organ Specific Cancers, Childhood cancer, Anti-Cancer Drug Discovery & Therapy, Industrial cancer, Non-Hodgkin Lymphoma, Head and Neck Cancer, Gilomas, Kidney Cancer, Soft Tissue Sarcoma, AIDS-Related Cancer and etc..
prominent speakers from the industry with prodigious experiences.
leading professionals of the industry with valuable skills.
Emerging researchers in the respective field.
You will have a great opportunity to share your research concerns or challenges with the leading experts in the field.
You have an opportunity to raise your doubts and getting answers from the experts.

What is Cancer Care 2019 ?

The new science redefining cancer as a large number of narrowly defined diseases and yielding therapeutic options for an expanding number of patients is rapidly transforming the oncology treatment landscape.

Most health systems are struggling to adapt and embrace this evolution—including the regulatory systems, skilled professionals, diagnostic and treatment infrastructures, and financing mechanisms that are required to serve the needs of cancer patients around the world. These challenges demand urgent attention in light of the strong near-term pipeline of clinically distinctive therapies, and new programs.

The surge of innovation in cancer treatments is catching the attention of health system stakeholders and participants around the world. Providers and patients have more choices – and face more complexity - in treatment options, including the possibility of dramatic increases in progression free and overall survival. Payers are also noticing the impact on drug budgets of longer treatment duration and increased numbers of patients receiving treatment. The focus of the second series of this conference would address these factors.

Who to attend Cancer Care 2019?

Dean, Department heads, Professors, Associate Professors, Assistant Professors, PhD Scholars, Graduates, Post Graduates, Junior/Senior Research Fellows and Scientists with a background in oncology related spectrum of study. Anesthesiologist, case manager, dermatologist, registered dietitian, Doctor of osteopathic medicine, dosimetrist, endocrinologist, enterostomal therapist, gastroenterologist , genetic counselor, gynecologic oncologist, hematologist , oncology clinical nurse specialist , medical oncologist , neonatologist, occupational therapist, oncologist, oncology social worker, otolaryngologist , pain specialists, palliative care specialists, pathologist, pediatric oncologist, psychologist, pulmonologist, radiation oncologist, radiation therapist, respiratory therapist, surgical oncologist, thoracic surgeons. Industrial specialists, CEOs, project heads of pharmaceutical companies, clinical trial R&D members, professionals of radiology, imaging, etc equipment industries.

Why to attend Cancer Care 2019 ?

☛ Every professional who wishes to be a part of the highest level of research and science should share and discuss her/his results and findings in a broad scientific spectrum.
☛ The best opportunity to do that is to attend scientific conferences, which enables one to get opinions and advice and to gain knowledge.
☛ Cancer care conference offers opportunities for making connections.
☛ This conference is a great way to learn about clinical trials, new treatments, and research into which of the old treatments still work best.
☛ This conference is a platform for industry solution providers and seekers are some of the best people for you to get to know, if you want to learn more about the current business climate.
☛ Discovering innovative products and services for your business is necessary to stay competitive in today’s fast-paced world.